Lanean...
Targeted Therapies in HER2-Positive Breast Cancer – a Systematic Review
About 20% of all breast cancer patients have a human epidermal growth factor receptor 2 (HER2)-positive breast tumor. This entity underwent an impressive change in prognosis, with notable improvement of progression-free survival and overall survival. Due to more aggressive tumors and no specific the...
Gorde:
| Argitaratua izan da: | Breast Care (Basel) |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
S. Karger Verlag für Medizin und Naturwissenschaften GmbH
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4569208/ https://ncbi.nlm.nih.gov/pubmed/26557822 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000431029 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|